ストックスクリーナーアプリを入手
19.88
0.30%
-0.06
アフターアワーズ：
20.00
0.12
+0.60%
Anaptysbio Inc (ANAB) 最新ニュース
AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates - MSN
AnaptysBio, Inc. (ANAB) Tops Q3 EPS by 56c - StreetInsider.com
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Anaptys Announces Participation in November and December Investor Conferences - The Manila Times
AnaptysBio (NASDAQ:ANAB) Stock Price Down 5.4%Should You Sell? - MarketBeat
Things To Consider Before Buying AnaptysBio Inc (NASDAQ: ANAB) - Stocks Register
AnaptysBio: Too Risky, Especially After GSK Drops Its Related Programs (NASDAQ:ANAB) - Seeking Alpha
AnaptysBio (ANAB) Shares Plunge as Eli Lilly Ends Arthritis Drug Research - GuruFocus.com
AnaptysBio (NASDAQ:ANAB) Given "Buy" Rating at HC Wainwright - MarketBeat
(ANAB) Trading Advice - Stock Traders Daily
AnaptysBio (NASDAQ:ANAB) Shares Gap DownWhat's Next? - MarketBeat
AnaptysBio (NASDAQ:ANAB) PT Raised to $33.00 - MarketBeat
AnaptysBio plunges as Eli Lilly drops co's arthritis drug from pipeline - XM
AnaptysBio stock falls as Lilly updates pipeline (ANAB:NASDAQ) - Seeking Alpha
O-I Glass Posts Downbeat Results, Joins AMD, Qorvo And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - TradingView
Assenagon Asset Management S.A. Grows Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio (NASDAQ:ANAB) Trading Down 6.9%Here's Why - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Receives $54.64 Consensus Price Target from Analysts - MarketBeat
AnaptysBio (NASDAQ:ANAB) PT Raised to $90.00 - Defense World
nVerses Capital LLC Buys 1,400 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Guggenheim reiterates buy rating on AnaptysBio stock, sees favorable risk/reward ahead of December readout - Investing.com Canada
A Glimpse Into The Expert Outlook On AnaptysBio Through 6 Analysts - Benzinga
AnaptysBio (NASDAQ:ANAB) PT Raised to $90.00 at Guggenheim - MarketBeat
(ANAB) On The My Stocks Page - Stock Traders Daily
AnaptysBio (NASDAQ:ANAB) Shares Down 4.9%Here's Why - MarketBeat
Piper Sandler reiterates stock target, overweight on AnaptysBio post-UEGW By Investing.com - Investing.com Canada
AnaptysBio (NASDAQ:ANAB) Trading 6.5% HigherStill a Buy? - MarketBeat
Antibody Library Technology Market Report to 2032 -AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen – IndiaPolitics.com - IndiaPolitics.com
RCM Technologies, Inc. (NASDAQ:RCMT) Shares Sold by Squarepoint Ops LLC - Defense World
Objective long/short (ANAB) Report - Stock Traders Daily
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Millennium Management LLC - MarketBeat
Dimensional Fund Advisors LP Has $8.42 Million Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
Point72 Asset Management L.P. Decreases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio (NASDAQ:ANAB) Shares Down 3.2%Should You Sell? - MarketBeat
AnaptysBio (NASDAQ:ANAB) Shares Down 3.2% – Time to Sell? - Defense World
AnaptysBio shares hold as Piper Sandler keeps Overweight rating By Investing.com - Investing.com Canada
Susquehanna Fundamental Investments LLC Has $1.81 Million Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
Anaptysbio BTLA agonist reduces atopic dermatitis inflammation - BioWorld Online
Frazier Life Sciences Management L.P. Has $54.27 Million Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Ensign Peak Advisors Inc - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Receives $51.10 Consensus Target Price from Analysts - MarketBeat
Wedbush Reaffirms Outperform Rating for AnaptysBio (NASDAQ:ANAB) - MarketBeat
What Analysts Are Saying About AnaptysBio Stock - Benzinga
AnaptysBio Insiders Selling US$3.6m In Stock Relieved As Market Cap Slides To US$1.1b - Simply Wall St
Alpha DNA Investment Management LLC Takes Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
Alpha DNA Investment Management LLC Invests $399,000 in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio chief medical officer sells shares worth over $58,000 By Investing.com - Investing.com Australia
AnaptysBio chief medical officer sells shares worth over $58,000 - Investing.com
Daily Progress: Adaptive Biotechnologies Corp (ADPT) Drop -8.39, Closing at 4.26 - The Dwinnex
Mount Yale Investment Advisors LLC Reduces Stake in ServiceNow, Inc. (NYSE:NOW) - Defense World
Applied Dna Sciences Inc (APDN) Stock: A Year of Market Fluctuations - The InvestChronicle
The ADPT Stock Puzzle: Unraveling Adaptive Biotechnologies Corp’s Fluctuating Performance - The InvestChronicle
APi Group Co. (NYSE:APG) Shares Sold by Progeny 3 Inc. - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Stock Position Reduced by First Light Asset Management LLC - MarketBeat
Analysts’ Weekly Ratings Changes for Adicet Bio (ACET) - Defense World
AnaptysBio (NASDAQ:ANAB) Shares Down 4.6% - MarketBeat
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):